Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02378896 · ClinicalTrials.gov registry record · NA

Personalized Computerized Inhibitory Control Training for OCD

A NA study of Obsessive - Compulsive Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT02378896 is a NA study of Obsessive - Compulsive Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 11 participants, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02378896, a NA study of Obsessive - Compulsive Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy
  • BEHAVIORAL Personalized Computer Program

Study Locations (1)

New York

  • New York State Psychiactic Institute - New York

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-02
Est. Completion 2018-01
Phase NA

What the Registry Record Tells You About NCT02378896

The ClinicalTrials.gov registry entry for NCT02378896 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.

NCT02378896 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02378896 about?

NCT02378896 is a clinical study titled "Personalized Computerized Inhibitory Control Training for OCD". This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

What is the current status of trial NCT02378896?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2015-02. Estimated completion is 2018-01.

What conditions does trial NCT02378896 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT02378896?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Personalized Computer Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02378896?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02378896 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.